June 21, 2024
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Amgen secures federal win for psoriasis drug

IN THIS ARTICLE

Amgen's new research and development facility in San Francisco. (courtesy photo) A federal appeals court has largely sided with Thousand Oaks-based biotech giant Amgen in a patent infringement suit it brought against two other life sciences firms over its psoriasis drug Otezla. The court on April 19 upheld a permanent injunction issued by a lower…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.